Provectus Pharmatech, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 47
Rang # Quantité totale PI 29 411
Note d'activité PI 2,4/5.0    35
Rang # Activité PI 21 706
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

24 2
10 0
11 0
0
 
Dernier brevet 2024 - Anti-bacterial effect of halogen...
Premier brevet 1999 - Improved method for targeted top...
Dernière marque 2022 - VERIPURE
Première marque 2015 - PV-10

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric so...
Invention Anti-bacterial effect of halogenated fluoresceins against colistin-resistant gram-negative bacter...
Invention Halogenated xanthenes as vaccine adjuvants. A method of inducing a Type I interferon response in...
2022 Invention Halogenated xanthene-containing topical anti-gram-positive bacterial ophthalmic composition and m...
Invention Photodynamic anti-gram-positive bacterial activity of pharmaceutical-grade rose bengal. This inv...
Invention Photodynamic anti-gram-positive bacterial activity of pharmaceutical-grade rose bengal. This inve...
P/S diagnostic reagents for in virology, microbiology and ophthalmology Medicinal and pharmaceutical ...
Invention Halogenated xanthene composition and method for treating hematologic cancers. 4 alkyl ester there...
2021 Invention Halogenated xanthenes as vaccine adjuvants. A method of inducing a Type I interferon response in ...
Invention Combination of local and systemic therapies for enhanced treatment of dermatologic conditions. A...
Invention Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer. A...
Invention In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric...
Invention Composition and method for oral treatment of leukemia. A method of treating a mammalian subject h...
Invention Treatment of solid cancerous tumors by oral administration of a halogenated xanthene. The present...
Invention Treatment of solid cancerous tumors by oral administration of a halogenated xanthene. The presen...
Invention Uses of halogenated xanthenes in oncology and virology. A method for treating a viral infection o...
Invention Novel uses of halogenated xanthenes in oncology and virology. in vivo in vivo or present in a mam...
2019 Invention Composition and method for treating hematologic cancers. A method of treating a mammalian subject...
Invention Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer. A ...
2018 Invention Combination of local and systemic therapies for enhanced treatment of dermatologic conditions. A ...
Invention Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molec...
2017 Invention Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment o...
2015 P/S Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment a...
Invention Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of canc...
Invention Combination of local and systemic immunomodulative therapies for melanoma and liver cancer. A met...
2014 Invention Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′, 4′, 5′7′-tetraiodo-3h-spiro[...
2013 Invention Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3h-spiro[i...
2010 Invention Intracorporeal medicaments for photodynamic treatment of disease. New intracorporeal photodynami...
Invention Process for the synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[i...
2009 Invention Intracorporeal medicaments for high energy phototherapeutic treatment of disease. New intracorpo...